Booster vaccinations reduced risk of death from COVID-19 in 2022 Booster vaccinations reduced the risk of dying from COVID-19 in 2022. The risk of death from other causes was also lower for people who had a booster jab than for people without a booster jab. These findings are from research by RIVM.
COVID-19 pandemic made me miss out on a key stage of my life, young people claim Young people aged 12–25 feel that the COVID-19 pandemic made them miss out on a key stage of their lives. They have indicated that important milestones, such as graduation ceremonies or the start of student life, passed them by. This is evident from the latest quarterly study conducted by the Network for Health Research in Disasters.
No reduction in number of young people with suicidal thoughts Even after a period without any coronavirus measures, the number of young people (aged 12-25 years) with serious suicidal thoughts remains high (16%). After nearly doubling in the last lockdown period (from 9% in autumn 2021 to 17% between December 2021 and February 2022), there has been almost no reduction in this percentage.
Autumn wave of COVID-19 may be starting: vaccination and testing are key Infections with the coronavirus SARS-CoV-2 in the Netherlands have been increasing for the past few weeks. Hospital admissions are also on the rise.
Effect of air cleaners on COVID-19 not yet clear It is not yet clear whether air cleaners that can be moved around actually help to reduce transmission of the coronavirus SARS-CoV-2. These findings are from a literature review conducted by RIVM.
Hypersensitivity reactions to fillers may occur after COVID-19 vaccination People may experience hypersensitivity reactions to fillers following a COVID-19 vaccination.
First clients and care workers in mental healthcare vaccinated on Monday The first mental health clients in inpatient or residential care in four large institutions in the Netherlands will be vaccinated against COVID-19 this week.
New research in GGD test lanes on spread of coronavirus SARS-CoV-2 RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2. The participants in this study are people who get tested for COVID-19 in a GGD test lane.
New variants disrupt plans In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.
One person died shortly after COVID-19 vaccination The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.